Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast ButtonSwitch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Stay Informed: Medical and Research Updates
Connect With Us!
 

 
PreviousPauseNext
Now is the Moment to Stop Alzheimer's Disease
About Alzheimer's Disease
Alzheimer's Disease: Get Involved
Alzheimer's Disease Questions and Answers
Alzheimer's Disease Research
Alzheimer's Disease Resources
About Alzheimer's Disease
Learn about what Alzheimer's disease is, its symptoms & risk factors, treatment options and how to live with or care for someone with the disease.
Ask an Expert
How long should a patient with Alzheimer's disease continue taking galantamine and Namenda? Is there any time limitation for taking these medications? My father has taken them for more than two years. Thank you for your advice. [ 05/03/13 ]

Although the therapeutic effects of galantamine and memantine (Namenda) may be modest for many patients, other patients may derive a longer and/or greater degree of benefit. The benefits may extend beyond helping memory and other cognitive functions. For some patients, the benefits include delayed deterioration of “activities of daily living,” delayed emergence of “non-cognitive behavioral symptoms,” and diminished “caregiver burden” (less time per day needed for caretaking). When addressing this concern with families, I ask them what they think the patient’s wishes would be at this stage of illness if he or she were able to make the decision. For some people, withdrawal of supportive treatment might be the appropriate choice. But keep in mind that patients taken off these medications even in a late stage might then deteriorate more quickly.


Last Review: 04/29/13

Shop for a Cause YouTube Twitter Connect With Us Pinterest Google+